TMCnet News

Trestle to Participate in Disaster Response Demonstration at the American Telemedicine Association Annual Conference
[April 30, 2004]

Trestle to Participate in Disaster Response Demonstration at the American Telemedicine Association Annual Conference

TAMPA, Fla. --(Business Wire)-- April 30, 2004 -- Trestle's MedMicro(TM) to Be Showcased in a Demonstration of Civilian and Military Telemedicine Applications for Use in Disaster Response -0- *T WHO: Trestle Corp., a supplier of digital imaging and telemedicine applications WHAT: Trestle will showcase its MedMicro(TM) live digital imaging product, and MedReach(TM), the Company's telemedicine application, throughout the American Telemedicine Disease Association's annual conference May 2-5, 2004. In addition, MedMicro is a key component in the conference's new Medical Disaster Response Demonstration (MEDRED) on Tuesday, May 4, 2004. MEDRED is a unique exercise designed to illustrate the feasibility of telemedicine technologies to work in conjunction with the American Red Cross, the public health system and local/regional service providers in a hypothetical disaster scenario in which a threat is posed to a heavily populated area. MedMicro, the Company's patented, live digital imaging product, allows multiple physicians and scientists to remotely view, navigate, and share high fidelity microscope images at sub-micron resolution over standard Internet connections in real-time. WHEN: ATA Conference, May 2-5, 2004 MEDRED will be held Tuesday, May 4, 2004 WHERE: ATA 2004 Ninth Annual Meeting & Exposition Booth #601 Tampa Convention Center, Tampa, Fla. CONTACT: Desiree Sites Director, Corporate Marketing 949-673-1907 [email protected] *T

About Trestle Holdings Inc.

Trestle Holdings develops and sells digital imaging and telemedicine applications to the life sciences markets. The Company's products, MedReach(TM), MedMicro and MedScan(TM), link dispersed users with each other, information databases and analytical tools. This improved integration drives cost savings and process efficiencies, enables improved pre-clinical and clinical phases of research and development for new drugs, and enhances patient care. For more information about Trestle Holdings and its digital imaging and network medicine applications, please visit the Company's Web site at www.trestlecorp.com.

[ Back To TMCnet.com's Homepage ]